CivicKnodeCivicKnowA project of CivicKnode
Sign in

HB 248

Did not advanceCrossfile SB 302
Add to calendar

Legionnaires' Disease Prevention Act

Sponsor: Vaughn Stewart (District 19)Committee: Environment and TransportationSubject: EnvironmentStatus: Hearing 2/02 at 1:00 p.m. (as of Nov 15, 2022)

What this bill does

Official synopsis

Requiring the Department of the Environment, by October 1, 2022, to adopt regulations requiring an owner or operator of a public building to establish and implement a water management program to prevent the growth and spread of Legionella pneumophila in a building water system to reduce the risk for Legionnaires' disease.

AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.

Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.

Testimony (18)

MGA witness list
FAV 11FavorableFWA 1Favorable with amendmentsUNF 4UnfavorableINFO 2Information only

Organizations on record

Registered lobbyists who testified

UNFPopham, BrysonBryson F. Popham, P.A.Registered for: Agency Insurance Company of Maryland; Agency Services, Inc.; Army Alliance; Bryson F. Popham P.A.; Building Owners and Managers Association of Greater Baltimore (BOMA); CVS Health
UNFWoolums, JohnMaryland Assn. of Boards of EducationRegistered for: Maryland Association of Boards of Education
UNFNibber, D'PaulMaryland Association of Counties (MACo)Registered for: American Heart Association
UNFWiggins, GrasonMaryland Multi-Housing AssociationRegistered for: Maryland Chamber of Commerce; United Way of Central Maryland, Inc.; Madison Marquette Property Investments LLC; Maryland Automobile Insurance Fund; Family Tree, The; OVG Facilities
INFOPaddy, MichaelMaryland Hospital AssociationRegistered for: American Cancer Society Cancer Action Network; Campaign to Protect Patient Health d/b/a Value of Care Coalition; Chase Brexton Health System; Diabetes Patient Advocacy Coalition; Gaudenzia, Inc.; Gilead Sciences, Inc.